Organon & Co (OGN)
18.42
-0.29
(-1.55%)
USD |
NYSE |
Apr 25, 16:00
18.51
+0.09
(+0.49%)
After-Hours: 17:12
Organon Market Cap: 4.709B for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 24, 2024 | 4.783B |
| April 23, 2024 | 4.734B |
| April 22, 2024 | 4.601B |
| April 19, 2024 | 4.555B |
| April 18, 2024 | 4.566B |
| April 17, 2024 | 4.568B |
| April 16, 2024 | 4.548B |
| April 15, 2024 | 4.527B |
| April 12, 2024 | 4.461B |
| April 11, 2024 | 4.673B |
| April 10, 2024 | 4.642B |
| April 09, 2024 | 4.706B |
| April 08, 2024 | 4.642B |
| April 05, 2024 | 4.566B |
| April 04, 2024 | 4.568B |
| April 03, 2024 | 4.578B |
| April 02, 2024 | 4.635B |
| April 01, 2024 | 4.729B |
| March 28, 2024 | 4.806B |
| March 27, 2024 | 4.717B |
| March 26, 2024 | 4.632B |
| March 25, 2024 | 4.555B |
| March 22, 2024 | 4.545B |
| March 21, 2024 | 4.678B |
| March 20, 2024 | 4.640B |
| Date | Value |
|---|---|
| March 19, 2024 | 4.586B |
| March 18, 2024 | 4.553B |
| March 15, 2024 | 4.673B |
| March 14, 2024 | 4.694B |
| March 13, 2024 | 4.742B |
| March 12, 2024 | 4.671B |
| March 11, 2024 | 4.688B |
| March 08, 2024 | 4.717B |
| March 07, 2024 | 4.660B |
| March 06, 2024 | 4.594B |
| March 05, 2024 | 4.538B |
| March 04, 2024 | 4.446B |
| March 01, 2024 | 4.489B |
| February 29, 2024 | 4.451B |
| February 28, 2024 | 4.558B |
| February 27, 2024 | 4.612B |
| February 26, 2024 | 4.512B |
| February 23, 2024 | 4.729B |
| February 22, 2024 | 4.742B |
| February 21, 2024 | 4.737B |
| February 20, 2024 | 4.727B |
| February 16, 2024 | 4.783B |
| February 15, 2024 | 4.760B |
| February 14, 2024 | 4.182B |
| February 13, 2024 | 4.121B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.799B
Minimum
Nov 16 2023
9.980B
Maximum
Mar 02 2022
6.725B
Average
7.195B
Median
Market Cap Benchmarks
| Merck & Co Inc | 331.78B |
| Alnylam Pharmaceuticals Inc | 18.10B |
| Amgen Inc | 144.47B |
| Biogen Inc | 29.43B |
| Pacira BioSciences Inc | 1.186B |
Market Cap Related Metrics
| PE Ratio | 4.605 |
| PS Ratio | 0.7537 |
| PEG Ratio | 0.4033 |
| Price to Free Cash Flow | 8.774 |
| Price | 18.42 |
| Earnings Yield | 21.72% |
| PEGY Ratio | 0.2645 |
| Operating PE Ratio | 3.557 |
| Normalized PE Ratio | 4.244 |